Latest Trends in Next Generation Sequencing Market by 2022

1. Market Opportunities and Forecasts2014–2022

2. Next Generation SequencingMarket–Introduction NGS is also known as high-throughput and massive parallelization sequencing technology. In the NGS process, genetic material is extracted, fragmented, and linked to adapters and primers for the amplification reaction (PCR) for library construction. Sequencing of the fragmented genetic material is executed, NGS furnishes a massive set of sequence data in a very small duration. This data is further interpreted and analyzed by clinicians, researchers, scientists and others through clinical, agricultural, forensic, and other applications For instance, NGS has helped researchers identify desirable traits, which have led to resilient and productive livestock and crops. The increase in usage and application of NGS is expected to boost the market growth. Next Generation Sequencing (NGS) Market Report, published by Allied Market Research, forecasts that the global market was valued at $3,567 million in 2015, and is expected to reach $12,801 million in 2022, supported by a CAGR of 19.9% during the forecast period 2016 - 2022. The consumables product segment held nearly three-fifths of the market share in 2015.

3. Introduction Scopeof theReport KeyBenefits KeyAudiences

4. KeyBenefits Introduction toSmart Syringes Market • The study provides an in-depth analysis of the global next generation sequencing market, with current trends and future estimations to elucidate the imminent investment pockets. • A quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities is discussed. • Key market players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the market. • Porters Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players. Syntheticbiologyisanovelareaofresearchthatistheamalgamationofmultipledisciplinessuch as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist innature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in themarket

5. Table ofContents: Introduction Executive Summary Market Overview Global Next Generation Sequencing Market, By Product Global Next Generation Sequencing Market, By Application Global Next Generation Sequencing Market, By Technology Global Next Generation Sequencing Market, By End Users Company Profiles Get sample copy of this reportat:https://www.alliedmarketresearch.com/request-sample/2048

6. Next Generation SequencingMarket–Segments

7. Next Generation SequencingMarket–Segments Introduction toSmart Syringes Market

8. Next Generation SequencingMarket–Segments Introduction toSmart Syringes Market

9. Next Generation SequencingMarket–Segments

10. Company Profile AGILENT TECHNOLOGIES, INC. BEIJING GENOMICS INSTITUTE GENOMATIX GMBH ILLUMINA, INC. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PERKINELMER, INC. PIERIANDX QIAGEN N.V. ROCHE HOLDING AG THERMO FISHER SCIENTIFIC, INC.

11. ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/next-generation-sequencing-market Follow UsOn